Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: An evidence-based review

Head and Neck

Volumn 36, Issue 3, 2014, Pages 431-443

  Paleri, Vinidh ^a   Roe, Justin W G ^b   Strojan, Primož ^c   Corry, June ^d   Grégoire, Vincent ^e   Hamoir, Marc ^e   Eisbruch, Avraham ^f   Mendenhall, William M ^g   Silver, Carl E ^h   Rinaldo, Alessandra ⁱ   Takes, Robert P ^j   Ferlito, Alfio ⁱ  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c INSTITUTE OF ONCOLOGY   (Slovenia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^f UNIVERSITY OF MICHIGAN   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ UNIVERSITY OF UDINE   (Italy)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

chemoradiation; dysphagia; IMRT; swallowing exercise; tube feeding

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ACUTE TOXICITY; CANCER CELL; CASE CONTROL STUDY; CHEMORADIOTHERAPY; CLINICAL PRACTICE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIET SUPPLEMENTATION; DRINKING; DYSPHAGIA; EATING; ENTERIC FEEDING; ERYTHEMA; ESOPHAGUS; ESOPHAGUS STENOSIS; EVIDENCE BASED PRACTICE; EXERCISE; FEEDING APPARATUS; FIBROSIS; FOLLOW UP; FUNCTIONAL STATUS; GASTROSTOMY; HEAD AND NECK CANCER; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; IRRADIATION; JAW MOTION REHABILITATION SYSTEM; LARYNX CANCER; MASSAGE; MORBIDITY; MUCOSA INFLAMMATION; MYOFIBROSIS; NASOGASTRIC TUBE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN PRESERVATION; ORGANS AT RISK; OROPHARYNX CANCER; OUTCOME ASSESSMENT; PARAMEDICAL PERSONNEL; PATIENT COMPLIANCE; PATIENT PREFERENCE; PHASE 2 CLINICAL TRIAL (TOPIC); PHYSIOTHERAPY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RANGE OF MOTION; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SPEECH AND LANGUAGE THERAPIST; STOMACH TUBE; STRETCHING; SWALLOWING; TASTE; TISSUE STRUCTURE; TREATMENT PLANNING; UNITED KINGDOM; UNITED STATES; WART VIRUS; WEIGHT REDUCTION; XEROSTOMIA;

CHEMORADIATION; DYSPHAGIA; IMRT; SWALLOWING EXERCISE; TUBE FEEDING;

CHEMORADIOTHERAPY; DEGLUTITION DISORDERS; ENTERAL NUTRITION; EXERCISE THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 84894245843     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23251     Document Type: Review

References (73)

1. Lewin JS,. Dysphagia after chemoradiation: prevention and treatment. Int J Radiat Oncol Biol Phys 2007; 69: S86-S87.
2. Wilson JA, Carding PN, Patterson JM,. Dysphagia after nonsurgical head and neck cancer treatment: patients' perspectives. Otolaryngol Head Neck Surg 2011; 145: 767-771.
3. Nguyen NP, Frank C, Moltz CC, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2005; 61: 772-778.
4. Trotti A, Pajak TF, Gwede CK, et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol 2007; 8: 613-624.
5. Lazarus CL,. Effects of chemoradiotherapy on voice and swallowing. Curr Opin Otolaryngol Head Neck Surg 2009; 17: 172-178.
6. Langmore S, Krisciunas GP, Miloro KV, Evans SR, Cheng DM,. Does PEG use cause dysphagia in head and neck cancer patients?. Dysphagia 2012; 27: 251-259.
7. Roe JW, Carding PN, Rhys-Evans PH, Newbold KL, Harrington KJ, Nutting CM,. Assessment and management of dysphagia in patients with head and neck cancer who receive radiotherapy in the United Kingdom-a web-based survey. Oral Oncol 2012; 48: 343-348.
8. Krisciunas GP, Sokoloff W, Stepas K, Langmore SE,. Survey of usual practice: dysphagia therapy in head and neck cancer patients. Dysphagia 2012; 27: 538-549.
9. National Institute for Clinical Excellence (NICE). Improving Outcomes in Head and Neck Cancer. London: NICE; 2004.
10. van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Rasch CR, Hilgers FJ,. A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemoradiotherapy: feasibility, compliance, and short-term effects. Dysphagia 2011; 26: 155-170.
11. Carnaby-Mann G, Crary MA, Schmalfuss I, Amdur R,. " Pharyngocise": randomized controlled trial of preventative exercises to maintain muscle structure and swallowing function during head-and-neck chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012; 83: 210-219.
12. Kulbersh BD, Rosenthal EL, McGrew BM, et al. Pretreatment, preoperative swallowing exercises may improve dysphagia quality of life. Laryngoscope 2006; 116: 883-886.
13. Carroll WR, Locher JL, Canon CL, Bohannon IA, McColloch NL, Magnuson JS,. Pretreatment swallowing exercises improve swallow function after chemoradiation. Laryngoscope 2008; 118: 39-43.
14. Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001; 127: 870-876.
15. Pauloski BR, Rademaker AW, Logemann JA, et al. Pretreatment swallowing function in patients with head and neck cancer. Head Neck 2000; 22: 474-482.
16. Stenson KM, MacCracken E, List M, et al. Swallowing function in patients with head and neck cancer prior to treatment. Arch Otolaryngol Head Neck Surg 2000; 126: 371-377.
17. van der Molen L, van Rossum MA, Ackerstaff AH, Smeele LE, Rasch CR, Hilgers FJ,. Pretreatment organ function in patients with advanced head and neck cancer: clinical outcome measures and patients' views. BMC Ear Nose Throat Disord 2009; 9: 10.
18. Ahlberg A, Engstrom T, Nikolaidis P, et al. Early self-care rehabilitation of head and neck cancer patients. Acta Otolaryngol 2011; 131: 552-561.
19. Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999; 17: 1008-1019.
20. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
21. van der Molen L, van Rossum M, Smeele L, Rasch C, Hilgers F,. Preventative rehabilitation in advanced chemo-radiated head and neck cancer patients; 2-year results. In: Proceedings of the 20th Annual Meeting of the Dysphagia Research Society; March 8-10, 2012; Toronto, Ontario, Canada; 2012.
22. Ricchetti F, Wu B, McNutt T, et al. Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 2011; 80: 161-168.
23. Kotz T, Federman AD, Kao J, et al. Prophylactic swallowing exercises in patients with head and neck cancer undergoing chemoradiation: a randomized trial. Arch Otolaryngol Head Neck Surg 2012; 138: 376-382.
24. Crary MA, Mann GD, Groher ME,. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil 2005; 86: 1516-1520.
25. List MA, Ritter-Sterr C, Lansky SB,. A performance status scale for head and neck cancer patients. Cancer 1990; 66: 564-569.
26. Focht K, Simpson K, Day T, Martin-Harris B,. Markov modelling to evaluate pre-treatment swallowing exercises in head and neck cancer. In: Proceedings of the 20th Annual Meeting of the Dysphagia Research Society; March 8-10, 2012; Toronto, Ontario, Canada; 2012.
27. Retel VP, van der Molen L, Hilgers FJ, et al. A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy. BMC Cancer 2011; 11: 475 (abstract).
28. Ackerstaff AH, Balm AJ, Rasch CR, et al. First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial. Head Neck 2009; 31: 77-84.
29. Rasch CR, Hauptmann M, Schornagel J, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer 2010; 116: 2159-2165.
30. Roe JW, Ashforth KM,. Prophylactic swallowing exercises for patients receiving radiotherapy for head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2011; 19: 144-149.
31. Carnaby G, Lagorio L, Crary M, Amdur R, Schmalfuss I,. Dysphagia prevention exercises in head and neck cancer: pharyngocise dose response study. In: Proceedings of the 20th Annual Meeting of the Dysphagia Research Society, March 8-10, 2012; Toronto, Ontario, Canada; 2012.
32. Lagorio L, Carnaby G,. Impact of baseline factors on adherence to a preventative swallowing exercise (Pharyngocise) during CRT in head and neck cancer patients. In: Proceedings of the 20th Annual Meeting of the Dysphagia Research Society, March 8-10, 2012; Toronto, Ontario, Canada; 2012.
33. Langmore SE, Krisciunas GP,. Dysphagia after radiotherapy for head and neck cancer: etiology, clinical presentation and efficacy of current treatments. Perspectives on swallowing and swallowing disorders (dysphagia). American Speech-Language-Hearing Association Division 2010; 19: 32-38.
34. Paleri V, Patterson J,. Use of gastrostomy in head and neck cancer: a systematic review to identify areas for future research. Clin Otolaryngol Allied Sci 2010; 35: 177-189.
35. Corry J, Poon W, McPhee N, et al. Randomized study of percutaneous endoscopic gastrostomy versus nasogastric tubes for enteral feeding in head and neck cancer patients treated with (chemo)radiation. J Med Imaging Radiat Oncol 2008; 52: 503-510.
36. Corry J, Poon W, McPhee N, et al. Prospective study of percutaneous endoscopic gastrostomy tubes versus nasogastric tubes for enteral feeding in patients with head and neck cancer undergoing (chemo)radiation. Head Neck 2009; 31: 867-876.
37. Magne N, Marcy PY, Foa C, et al. Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients. Eur Arch Otorhinolaryngol 2001; 258: 89-92.
38. Mekhail TM, Adelstein DJ, Rybicki LA, Larto MA, Saxton JP, Lavertu P,. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?. Cancer 2001; 91: 1785-1790.
39. Oozeer NB, Corsar K, Glore RJ, Penney S, Patterson J, Paleri V,. The impact of enteral feeding route on patient-reported long term swallowing outcome after chemoradiation for head and neck cancer. Oral Oncol 2011; 47: 980-983.
40. Chen AM, Li BQ, Lau DH, et al. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2010; 78: 1026-1032.
41. Kerstein R, Patterson J, Owen S, Johnson K, Cocks H,. Severe hypopharyngeal stenosis following treatment for head a neck cancer-a case series In: 13th British Academic Conference in Otolaryngology 2009; Liverpool, UK; 2009.
42. Hutcheson KA, Lewin JS,. Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers. Curr Oncol Rep 2012; 14: 158-165.
43. Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12: 127-136.
44. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 2004; 60: 1425-1439.
45. Dornfeld K, Simmons JR, Karnell L, et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life. Int J Radiat Oncol Biol Phys 2007; 68: 750-757.
46. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007; 68: 1289-1298.
47. Caglar HB, Tishler RB, Othus M, et al. Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: 1110-1118.
48. Mendenhall WM, Amdur RJ, Morris CG, Kirwan JM, Li JG,. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma. Laryngoscope 2010; 120: 2218-2222.
49. Levendag PC, Teguh DN, Voet P, et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship. Radiother Oncol 2007; 85: 64-73.
50. Caudell JJ, Schaner PE, Desmond RA, Meredith RF, Spencer SA, Bonner JA,. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 2010; 76: 403-409.
51. van der Laan HP, Christianen ME, Bijl HP, Schilstra C, Langendijk JA,. The potential benefit of swallowing sparing intensity modulated radiotherapy to reduce swallowing dysfunction: an in silico planning comparative study. Radiother Oncol 2012; 103: 76-81.
52. Eisbruch A, Kim HM, Feng FY, et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys 2011; 81: e93-e99.
53. Frowen J, Cotton S, Corry J, Perry A,. Impact of demographics, tumor characteristics, and treatment factors on swallowing after (chemo)radiotherapy for head and neck cancer. Head Neck 2010; 32: 513-528.
54. Dabaja B, Salehpour MR, Rosen I, et al. Intensity-modulated radiation therapy (IMRT) of cancers of the head and neck: comparison of split-field and whole-field techniques. Int J Radiat Oncol Biol Phys 2005; 63: 1000-1005.
55. Webster GJ, Rowbottom CG, Ho KF, Slevin NJ, Mackay RI,. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck. Int J Radiat Oncol Biol Phys 2008; 72: 617-622.
56. Caudell JJ, Burnett OL III, Schaner PE, Bonner JA, Duan J,. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer. Int J Radiat Oncol Biol Phys 2010; 77: 462-467.
57. Schwartz DL, Hutcheson K, Barringer D, et al. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2010; 78: 1356-1365.
58. Christianen ME, Langendijk JA, Westerlaan HE, van de Water TA, Bijl HP,. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol 2011; 101: 394-402.
59. Mendenhall WM, Amdur RJ, Palta JR,. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol 2006; 24: 2618-2623.
60. Mendenhall WM, Mancuso AA,. Radiotherapy for head and neck cancer-is the "next level" down?. Int J Radiat Oncol Biol Phys 2009; 73: 645-646.
61. Wang JJ, Goldsmith TA, Holman AS, Cianchetti M, Chan AW,. Pharyngoesophageal stricture after treatment for head and neck cancer. Head Neck 2012; 34: 967-973.
62. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 2010; 28: 2732-2738.
63. Bhide SA, Gulliford S, Kazi R, et al. Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer. Radiother Oncol 2009; 93: 539-544.
64. Anand AK, Chaudhoory AR, Shukla A, et al. Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer. Br J Radiol 2008; 81: 865-871.
65. Salama JK, Stenson KM, List MA, et al. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2008; 134: 1060-1065.
66. Christianen ME, Schilstra C, Beetz I, et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol 2012; 105: 107-114.
67. Rosenthal DI, Lewin JS, Eisbruch A,. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 2006; 24: 2636-2643.
68. Chen AM, Li BQ, Jennelle RL, et al. Late esophageal toxicity after radiation therapy for head and neck cancer. Head Neck 2010; 32: 178-183.
69. Fua TF, Corry J, Milner AD, Cramb J, Walsham SF, Peters LJ,. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia. Int J Radiat Oncol Biol Phys 2007; 67: 976-981.
70. Lawson JD, Otto K, Grist W, Johnstone PA,. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer. Am J Otolaryngol 2008; 29: 13-19.
71. Lee NY, O'Meara W, Chan K, et al. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 2007; 69: 459-468.
72. Li B, Li D, Lau DH, et al. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy. Radiat Oncol 2009; 4: 52.
73. Peponi E, Glanzmann C, Willi B, Huber G, Studer G,. Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiat Oncol 2011; 6: 1.